CD8A and neoplasm: The underlying mechanism involves IPA elevating the levels of histone H3 lysine 27 acetylation at the enhancer site of the Tcf7 gene, thereby modulating the stemness program of CD8 + T cells and their differentiation into progenitor exhausted CD8 + T cells (Tpex), which in turn limits tumor progression [158].